Aquestive and IntelGenx Join Hands with Mens Health Company to Increase Market for Tadalafil Oral Films

Aquestive Therapeutics has signed a license and supply agreement with a leading men’s health company to make Tadalafil oral films available to men suffering from erectile dysfunction.

FREMONT, CA: “Securing this commercial partnership is a significant milestone in our innovative collaboration with Aquestive and represents another major step toward achieving our mutual goal of making Tadalafil oral films available to men suffering from ED and BPH,” states Dr. Horst G. Zerbe, CEO of IntelGenx. Aquestive Therapeutics, Inc., IntelGenx Corp.'s co-development and commercialization partner for Tadalafil oral films for the treatment of erectile dysfunction (ED) and benign prostatic hyperplasia (BPH) (the Product), has signed a definitive license and supply agreement with an undisclosed leading men's health company.

Aquestive Therapeutics is a pharmaceutical company that uses cutting-edge technology to solve therapeutic issues and improve patient care. To date, the company has only commercialized one internally-developed proprietary product, Sympazan® oral film, but it has a commercial proprietary product pipeline focused on the treatment of central nervous system diseases and other unmet needs, and it is developing orally-administered complex molecules as alternatives to invasively administered standard of care therapies. 

The company also works with other pharmaceutical companies to bring new compounds to market utilizing proprietary, best-in-class technologies, and it has demonstrated medication development and commercialization skills.

IntelGenx is a renowned drug delivery firm that specializes in pharmaceutical film research and production. VersaFilm®, DisinteQ, VetaFilm, and transdermal VevaDerm, among IntelGenx's excellent film technologies, enable next-generation pharmaceutical products to solve unmet medical requirements. For a variety of therapeutic situations, IntelGenx's breakthrough product pipeline provides considerable benefits to patients and physicians. IntelGenx's highly qualified staff provides pharmaceutical partners with a full range of services, including R&D, analytical method development, clinical monitoring, intellectual property, and regulatory services. IntelGenx's cutting-edge manufacturing facility provides a comprehensive range of services, from lab to pilot to commercial-scale production.